| Item Type | Name |
|
Concept
|
Transplantation, Heterologous
|
|
Concept
|
Kidney Transplantation
|
|
Concept
|
Liver Transplantation
|
|
Concept
|
Transplantation Tolerance
|
|
Concept
|
Transplantation
|
|
Concept
|
Heart Transplantation
|
|
Concept
|
Islets of Langerhans Transplantation
|
|
Concept
|
Organ Transplantation
|
|
Concept
|
Transplantation, Homologous
|
|
Academic Article
|
Recurrent autoimmune hepatitis after orthotopic liver transplantation.
|
|
Academic Article
|
Differential allograft gene expression in acute cellular rejection and recurrence of hepatitis C after liver transplantation.
|
|
Academic Article
|
Hepatitis G virus infection in patients transplanted for cryptogenic cirrhosis: red flag or red herring?
|
|
Academic Article
|
Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation.
|
|
Academic Article
|
Obesity, hyperlipidemia, and metabolic syndrome.
|
|
Academic Article
|
Natural history and management of hepatitis C infection after liver transplantation.
|
|
Academic Article
|
Predictors of cardiovascular events after liver transplantation: a role for pretransplant serum troponin levels.
|
|
Academic Article
|
A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C.
|
|
Academic Article
|
Recipient IL28B polymorphism is an important independent predictor of posttransplant diabetes mellitus in liver transplant patients with chronic hepatitis C.
|
|
Academic Article
|
Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantation.
|
|
Academic Article
|
Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation.
|
|
Academic Article
|
Preserving flow in liver transplant recipients: mTOR inhibitors everolimus and sirolimus are not peas from a pod.
|
|
Academic Article
|
Interleukin-28B and fibrosing cholestatic hepatitis in posttransplant hepatitis C: a case-control study and literature review.
|
|
Academic Article
|
Response to Fibrosis progression in patients treated for hepatitis C recurrence.
|
|
Academic Article
|
Liver transplantation for cryptogenic cirrhosis.
|
|
Academic Article
|
Recurrent and new hepatitis C virus infection after liver transplantation.
|
|
Academic Article
|
Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease.
|
|
Academic Article
|
A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation.
|
|
Academic Article
|
Pre-emptive treatment of recurrent hepatitis C infection.
|
|
Academic Article
|
Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.
|
|
Academic Article
|
Early detection of hepatitis C allograft reinfection after orthotopic liver transplantation: a molecular and histologic study.
|
|
Academic Article
|
Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation.
|
|
Academic Article
|
Mycophenolate and hepatitis C: salve on a wound or gasoline on a fire?
|
|
Academic Article
|
Hepatitis C infection in liver transplantation.
|
|
Academic Article
|
Retransplantation for HCV--the view through a broken crystal ball.
|
|
Academic Article
|
Predictors of patient and graft survival following liver transplantation for hepatitis C.
|
|
Academic Article
|
Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis.
|
|
Academic Article
|
Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases.
|
|
Academic Article
|
The impact of advancing donor age on histologic recurrence of hepatitis C infection: the perils of ignored maternal advice.
|
|
Academic Article
|
Characterization of hepatitis B virus surface antigen and polymerase mutations in liver transplant recipients pre- and post-transplant.
|
|
Academic Article
|
Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation.
|
|
Academic Article
|
Management of recurrence of hepatitis C infection following liver transplantation.
|
|
Academic Article
|
Origin of adenocarcinoma in a transplanted liver determined by microsatellite analysis.
|
|
Academic Article
|
Natural history of hepatitis C and outcomes following liver transplantation.
|
|
Academic Article
|
Long-term results and modeling to predict outcomes in recipients with HCV infection: results of the NIDDK liver transplantation database.
|
|
Academic Article
|
The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database.
|
|
Academic Article
|
A practical guide to the management of HCV infection following liver transplantation.
|
|
Academic Article
|
Recurrence of primary sclerosing cholangitis following liver transplantation.
|
|
Academic Article
|
Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
|
|
Academic Article
|
Impact of nutritional status on outcomes after liver transplantation.
|
|
Academic Article
|
Patient and graft survival following liver transplantation for hepatitis C: much ado about something.
|
|
Academic Article
|
Obesity in potential living donors: success with simplicity.
|
|
Academic Article
|
Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: results of a phase 2 randomized study.
|
|
Academic Article
|
Combined heart and liver transplantation: a single-center experience.
|
|
Academic Article
|
Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation.
|
|
Academic Article
|
Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study.
|
|
Academic Article
|
Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease.
|
|
Academic Article
|
Recurrence of hepatitis C infection: Where are we now?
|
|
Academic Article
|
Perioperative viral kinetics: new insights or the Emperor's new clothes?
|
|
Academic Article
|
Approach to recurrent hepatitis C following liver transplantation.
|
|
Academic Article
|
Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients.
|
|
Academic Article
|
Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection.
|
|
Academic Article
|
Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: an analysis of the Scientific Registry of Transplant Recipients Database.
|
|
Academic Article
|
Nutritional status of patients with alcoholic cirrhosis undergoing liver transplantation: time trends and impact on survival.
|
|
Academic Article
|
Reduction of immunosuppression for transplant-associated skin cancer: thresholds and risks.
|
|
Academic Article
|
Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C.
|
|
Academic Article
|
Antibody-based immunosuppression following liver transplantation: the plot thickens.
|
|
Academic Article
|
Posttransplant metabolic syndrome: new evidence of an epidemic and recommendations for management.
|
|
Academic Article
|
The clinical significance of simultaneous infection with hepatitis G virus in patients with chronic hepatitis C.
|
|
Academic Article
|
Genotype 1b and severity of posttransplant recurrence of hepatitis C infection- unconvictable felon or wrongly accused?
|
|
Academic Article
|
Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: lessons on tolerability and efficacy.
|
|
Academic Article
|
Fatty liver and liver transplantation.
|
|
Academic Article
|
Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
|
|
Academic Article
|
Chronic kidney disease (CKD) and NAFLD: time for awareness and screening.
|
|
Academic Article
|
Impact of fibrosis progression on clinical outcome in patients treated for post-transplant hepatitis C recurrence.
|
|
Academic Article
|
Lack of Survival Benefit Following Liver Transplantation With MELD Exception Points for Hepatocellular Carcinoma: Beyond the Unblinding of Lady Justice.
|
|
Academic Article
|
Retransplantation for hepatitis C: results of a U.S. multicenter retransplant study.
|
|
Academic Article
|
Daclizumab induction therapy in liver transplant recipients with renal insufficiency.
|
|
Academic Article
|
Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.
|
|
Academic Article
|
Investigation of PNPLA3 and IL28B genotypes on diabetes and obesity after liver transplantation: insight into mechanisms of disease.
|
|
Academic Article
|
Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents--a potentially lethal cocktail.
|
|
Academic Article
|
The lethal and enduring inequity of deceased donor liver allocation policy for hepatocellular carcinoma in the United States.
|
|
Academic Article
|
The impact of gender and NASH on chronic kidney disease before and after liver transplantation.
|
|
Academic Article
|
Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B.
|
|
Academic Article
|
Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation.
|
|
Academic Article
|
Hypophosphatemia after right hepatectomy for living donor liver transplantation.
|
|
Academic Article
|
Nonalcoholic fatty liver disease: a review of current understanding and future impact.
|
|
Academic Article
|
Asynchronous, out-of-sequence, transcontinental chain kidney transplantation: a novel concept.
|
|
Academic Article
|
Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection.
|
|
Academic Article
|
PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus.
|
|
Academic Article
|
Noninvasive diagnosis of acute cellular rejection in liver transplant recipients: a proteomic signature validated by enzyme-linked immunosorbent assay.
|
|
Academic Article
|
Ultrasound-based transient elastography for the detection of hepatic fibrosis in patients with recurrent hepatitis C virus after liver transplantation: a systematic review and meta-analysis.
|
|
Academic Article
|
Evolving aspects of liver transplantation for nonalcoholic steatohepatitis.
|
|
Academic Article
|
How important is acute cellular rejection?
|
|
Academic Article
|
Victory and defeat at Heraclea - treating hepatitis C infection following liver transplantation with telaprevir and boceprevir.
|
|
Academic Article
|
Serum adipokine and inflammatory markers before and after liver transplantation in recipients with major cardiovascular events.
|
|
Academic Article
|
Metabolic syndrome and liver transplantation: a review and guide to management.
|
|
Academic Article
|
Pretransplant serum troponin levels are highly predictive of patient and graft survival following liver transplantation.
|
|
Academic Article
|
The course of posttransplant hepatitis C infection: comparative impact of donor and recipient source of the favorable IL28B genotype and other variables.
|
|
Academic Article
|
Interleukin-28B polymorphism in hepatitis C and liver transplantation.
|
|
Academic Article
|
Sirolimus as a calcineurin inhibitor- and renal-sparing agent: all good things come to those who wait versus spare the nephron, spoil the patient.
|
|
Academic Article
|
Improving long-term outcomes after liver transplantation.
|
|
Academic Article
|
Treatment of HCV prior to liver transplantation to prevent HCV recurrence - wise or wasteful?
|
|
Academic Article
|
Hepatitis C Virus RNA Persists in Liver Explants of Most Patients Awaiting Liver Transplantation Treated With an Interferon-Free Regimen.
|
|
Academic Article
|
On-treatment HCV RNA in patients with varying degrees of fibrosis and cirrhosis in the SOLAR-1 trial.
|
|
Academic Article
|
Liver Transplantation for Alcoholic and Nonalcoholic Fatty Liver Disease: Pretransplant Selection and Posttransplant Management.
|
|
Academic Article
|
Nonalcoholic Fatty Liver Disease and Liver Transplantation.
|
|
Academic Article
|
Alcoholic Liver Disease and Liver Transplantation.
|
|
Academic Article
|
Roadmap for improving patient and graft survival in the next 10 years.
|
|
Academic Article
|
Usefulness of Liver Transplantation in the Elderly: The Converging Impact of Risk and Benefit.
|
|
Academic Article
|
Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation.
|
|
Academic Article
|
Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation.
|
|
Academic Article
|
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease.
|
|
Academic Article
|
Prevalence and clinical consequences of Hepatitis E in patients who underwent liver transplantation for chronic Hepatitis C in the United States.
|
|
Academic Article
|
Protecting the Kidney in Liver Transplant Candidates: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice.
|
|
Academic Article
|
Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
|
|
Academic Article
|
International Liver Transplant Society Consensus Statement on HEPATITIS C MANAGEMENT IN LIVER TRANSPLANT CANDIDATES.
|
|
Academic Article
|
A randomized, prospective, parallel group study of laparoscopic versus laparoendoscopic single site donor nephrectomy for kidney donation.
|
|
Academic Article
|
International Liver Transplant Society Consensus Statement on HEPATITIS C MANAGEMENT IN LIVER TRANSPLANT RECIPIENTS.
|
|
Academic Article
|
Predictors of Cardiovascular Events After Liver Transplantation.
|
|
Academic Article
|
International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates.
|
|
Academic Article
|
International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients.
|
|
Academic Article
|
The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation.
|
|
Academic Article
|
Everolimus Is Associated With Less Weight Gain Than Tacrolimus 2 Years After Liver Transplantation: Results of a Randomized Multicenter Study.
|
|
Academic Article
|
Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models.
|
|
Academic Article
|
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.
|
|
Academic Article
|
International Liver Transplantation Society Asian Consensus on the Management of Hepatitis C Virus Infection in Resource Limited Setting-From Noncirrhotic to Decompensated Disease and After Liver Transplantation.
|
|
Academic Article
|
Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
|
|
Academic Article
|
Liver Transplantation for Nonalcoholic Steatohepatitis: New Evidence of a Profound Increase Across Age Cohorts.
|
|
Academic Article
|
International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients.
|
|
Academic Article
|
Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors.
|
|
Academic Article
|
Improved Graft Survival After Liver Transplantation for Recipients With Hepatitis C Virus in the Direct-Acting Antiviral Era.
|
|
Academic Article
|
New organ allocation policy in liver transplantation in the United States.
|
|
Academic Article
|
Abnormal liver tests after liver transplantation.
|
|
Academic Article
|
Simultaneous heart, liver and kidney transplantation: A viable option for heart failure patients with multiorgan failure.
|
|
Academic Article
|
Nonalcoholic Steatohepatitis After Liver Transplantation.
|
|
Academic Article
|
Nonalcoholic fatty liver disease: impact on healthcare resource utilization, liver transplantation and mortality in a large, integrated healthcare system.
|
|
Academic Article
|
Liver transplantation for alcoholic hepatitis in the United States: Excellent outcomes with profound temporal and geographic variation in frequency.
|
|
Academic Article
|
Simultaneous Heart-Liver Transplantation for Congenital Heart Disease in the United States: Rapidly Increasing With Acceptable Outcomes.
|
|
Academic Article
|
Liver Transplantation of HCV-viremic Donors Into HCV-negative Recipients in the United States: Increasing Frequency With Profound Geographic Variation.
|
|
Academic Article
|
The demise of islet allotransplantation in the United States: A call for an urgent regulatory update.
|
|
Academic Article
|
En bloc liver and pancreas transplantation after total pancreatectomy with autologous islet transplantation.
|
|
Academic Article
|
Living Donor Liver Transplantation in the United States: Evolution of Frequency, Outcomes, Center Volumes, and Factors Associated With Outcomes.
|
|
Academic Article
|
The Authors' Reply: Geographic Variation in the Utilization of HCV-viremic Donors Into HCV-negative Recipients.
|
|
Academic Article
|
Preservation solutions for static cold storage in donation after circulatory death and donation after brain death liver transplantation in the United States.
|
|
Academic Article
|
Relatively Poor Long-term Outcomes Following Liver Transplantation for NASH in the United States.
|
|
Grant
|
REDUCTION OF HCV RECURRANCE AFTER LIVER TRANSPLANTATION
|
|
Academic Article
|
Liver Transplantation 2023: Status Report, Current and Future Challenges.
|